Sign up
Log in
George
China-Vaccine Incident/Disposal
Changchun City, Jilin Province, northeast China - Recent (CGTN - No access Chinese mainland)
1. Various of ChangSheng Life Sciences Ltd. building
2. Gate
Changchun City, Jilin Province, northeast China - July 27, 2018 (CCTV - No access Chinese mainland)
3. Various of vaccines
FILE: China - Exact Location, Date Unknown (CCTV - No access Chinese mainland)
4. Various of vaccine production line, workers
Changchun City, Jilin Province, northeast China - July 27, 2018 (CCTV - No access Chinese mainland)
5. Various of investigators checking production records
Jinan City, Shandong Province, east China - Recent (CGTN - No access Chinese mainland)
6. Various of nurse vaccinating child
7. Parents, children in hospital waiting room
China's State Council investigation team will step up efforts to investigate DPT vaccines and will hold to account officials who neglect their regulatory responsibilities.
The team's renewed efforts come after investigators discovered two batches of 499,800 defective DPT vaccines produced by Changchun Changsheng Life Sciences Limited.
The vaccines were sold to Shandong and Anhui provinces, and 76.2 percent of children who had been vaccinated from the first batch of unqualified DPT vaccines, labeled "201605014-01", have been revaccinated.
Meanwhile, health and drug authorities have made plans for those subjected to the second batch of vaccines, labeled "201605014-02", to renew their vaccinations.
In October 2017, DPT vaccines produced by Changchun Changsheng Life Sciences Limited were found to be defective. The company's production of DPT vaccines has since been suspended.
DPT refers to a combination of vaccines against three infectious diseases: diphtheria, pertussis, and tetanus.
China-Vaccine Incident/Disposal
Dateline : Aug 15/Jul 27, 2018/File/Recent
Location : Beijing,China
Duration : 1'27
Changchun City, Jilin Province, northeast China - Recent (CGTN - No access Chinese mainland)
1. Various of ChangSheng Life Sciences Ltd. building
2. Gate
Changchun City, Jilin Province, northeast China - July 27, 2018 (CCTV - No access Chinese mainland)
3. Various of vaccines
FILE: China - Exact Location, Date Unknown (CCTV - No access Chinese mainland)
4. Various of vaccine production line, workers
Changchun City, Jilin Province, northeast China - July 27, 2018 (CCTV - No access Chinese mainland)
5. Various of investigators checking production records
Jinan City, Shandong Province, east China - Recent (CGTN - No access Chinese mainland)
6. Various of nurse vaccinating child
7. Parents, children in hospital waiting room
China's State Council investigation team will step up efforts to investigate DPT vaccines and will hold to account officials who neglect their regulatory responsibilities.
The team's renewed efforts come after investigators discovered two batches of 499,800 defective DPT vaccines produced by Changchun Changsheng Life Sciences Limited.
The vaccines were sold to Shandong and Anhui provinces, and 76.2 percent of children who had been vaccinated from the first batch of unqualified DPT vaccines, labeled "201605014-01", have been revaccinated.
Meanwhile, health and drug authorities have made plans for those subjected to the second batch of vaccines, labeled "201605014-02", to renew their vaccinations.
In October 2017, DPT vaccines produced by Changchun Changsheng Life Sciences Limited were found to be defective. The company's production of DPT vaccines has since been suspended.
DPT refers to a combination of vaccines against three infectious diseases: diphtheria, pertussis, and tetanus.
ID : 8088122
Published : 2018-08-16 11:33
Last Modified : 2018-08-17 15:28:00
Source : China Central Television (CCTV),China Global Television Network (CGTN)
Restrictions : No access Chinese mainland
More
